Note 1 - Nature of Business (Details Textual) |
6 Months Ended | ||||
---|---|---|---|---|---|
Mar. 22, 2024 |
Mar. 21, 2024 |
Apr. 29, 2024 |
Jun. 30, 2024 |
May 05, 2023
$ / shares
|
|
Number of Core Drug Technologies | 3 | ||||
NASDAQ Compliance, Minimum Closing Bid Price Per Share (in dollars per share) | $ 1 | ||||
NASDAQ Compliance, Extension Period (Day) | 180 days | ||||
Reverse Stock Split [Member] | |||||
Stockholders' Equity Note, Stock Split, Conversion Ratio | 15 | 15 | |||
Animal Life Sciences, Inc [Member] | |||||
Equity Method Investment, Ownership Percentage | 10.00% |